Avid Bioservices Inc (CDMO)
10.52
+0.25
(+2.43%)
USD |
NASDAQ |
Nov 04, 13:00
Avid Bioservices Gross Profit Margin (Quarterly): 14.22% for July 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2024 | 14.22% |
| April 30, 2024 | 12.80% |
| January 31, 2024 | 7.05% |
| October 31, 2023 | -18.37% |
| July 31, 2023 | 10.87% |
| April 30, 2023 | 21.08% |
| January 31, 2023 | 25.84% |
| October 31, 2022 | 11.93% |
| July 31, 2022 | 24.85% |
| April 30, 2022 | 22.37% |
| January 31, 2022 | 28.84% |
| October 31, 2021 | 35.18% |
| July 31, 2021 | 37.04% |
| April 30, 2021 | 29.50% |
| January 31, 2021 | 28.44% |
| October 31, 2020 | 30.47% |
| July 31, 2020 | 33.65% |
| April 30, 2020 | -10.35% |
| January 31, 2020 | 5.78% |
| October 31, 2019 | 18.35% |
| July 31, 2019 | 7.12% |
| April 30, 2019 | 21.39% |
| January 31, 2019 | 14.88% |
| October 31, 2018 | 3.28% |
| July 31, 2018 | 9.47% |
| Date | Value |
|---|---|
| April 30, 2018 | -28.24% |
| January 31, 2018 | -60.60% |
| October 31, 2017 | -27.07% |
| July 31, 2017 | 24.48% |
| April 30, 2017 | 34.19% |
| January 31, 2017 | 25.80% |
| October 31, 2016 | 33.93% |
| July 31, 2016 | 45.41% |
| April 30, 2016 | 47.32% |
| January 31, 2016 | 41.93% |
| October 31, 2015 | 50.22% |
| July 31, 2015 | 52.35% |
| April 30, 2015 | 48.88% |
| January 31, 2015 | 45.16% |
| October 31, 2014 | 34.30% |
| July 31, 2014 | 34.81% |
| April 30, 2014 | 40.86% |
| January 31, 2014 | 37.81% |
| October 31, 2013 | 42.96% |
| July 31, 2013 | 43.05% |
| April 30, 2013 | 24.38% |
| January 31, 2013 | 48.13% |
| October 31, 2012 | 39.68% |
| July 31, 2012 | 52.39% |
| April 30, 2012 | 54.77% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-18.37%
Minimum
Oct 2023
37.04%
Maximum
Jul 2021
18.48%
Average
22.37%
Median
Apr 2022
Gross Profit Margin (Quarterly) Benchmarks
| MEI Pharma Inc | -- |
| Altimmune Inc | -- |
| NovaBay Pharmaceuticals Inc | 66.33% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -107.0% |
| Return on Assets | -35.62% |
| Return on Invested Capital | -51.31% |
| Profit Margin (Quarterly) | -13.78% |
| Operating Margin (Quarterly) | -6.11% |
| Return on Net Operating Assets | -49.36% |